Trial record 1 of 1 for:    MI-CP216
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01284231
Recruitment Status : Completed
First Posted : January 26, 2011
Last Update Posted : March 3, 2015
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2015
  Study Completion Date : January 2015